Bribery/Anti-corruption: Novartis (via The Lawyer) Mar 21, 2011 | Written by fraudblawg Thomas Werlen at The Lawyer comments on the $422 million fine against pharmaceutical giant Novartis for off-label marketing of the epilepsy drug, Trileptal.
Talk with an Expert
Frohsin Barger & Walthall
Call 205.933.4006 or
Send us a Message